Merit in Rajasthan Secondary Education Board Metrics Examination,     1984
  Won Piramal Gold Medal in Higher Secondary Examination, 1985
  Certificate of Proficiency from Bhagwan Mahaveer Cancer Hospital,     Jaipur (2001)
  Participated and won first prize in scientific quiz and other competition in     district level tournaments in school.

 Advisor, BMCHRC, News Bulletin

  Scientific Registrar, Medical Practitioners Society of Jaipur, 2007-2008.( Conducted 10 CME in various fields.)

  Associate Editor, Medic News (A Journal of Medical Practitioner Society of Jaipur)

  Member, Advisor Board, Bhagwan Mahaveer Cancer Hospital & Research Centre, New Bulletin, Jaipur

  Ex-Convener, Tumor Board, Bhagwan Mahaveer Cancer Hospital, Jaipur

  Ex-Vice-president, Rajasthan Cancer Detection & Welfare Society, Jaipur

  Founder & Secretary, Ratan Lal Somani Memorial Charitable Trust, Jaipur (Regd. & 80 cc Exempted).  Doing Charity Services since last 6 years in field of Health, Education & Helping Weaker Section of Society.

  Member, Management Committee B.L. Higher Secondary School, Bagar, (Raj.)

  Member, Management Committee of Shri Maheshawari Hospital & Research Center, Jaisalmer, Rajasthan - A remote/international border town of Rajasthan & conducting cancer camp regularly.

  Literary Secretary of S.M.S. Medical College – 1988

  Editor-in-chief: SMS Medical College Magazine (Sanjeevani) Jaipur – 1988

  All India Inter Medical badminton Championship – 2nd Position - 1989

  European Society of Medical Oncology (Full membership no. 4859/9407)

  Indian Society of Medical & Pediatrics Oncology

  Indian Cancer Society

  Executive Member of Indian Co-operative Oncology Network

  Association of Physician of India

  Indian Medical Association

  Indian Critical Care Society

  Treated and served more then 12,000 cancer patients

  One year experience of Leukemia / Lymphoma clinic – S.M.S. Medical College, Jaipur (1995-96)

  Professional Consulting Associated with G.L.G. Group (www.glggroup.com)

  ESO-SIOP Pediatric Oncology Workshop (1999), Chennai, India
  Asia-Pacific Cancer Conference (1999), Chennai, India

  ECCO-11, October 2001 – Lisbon Portugal

  UICC Conference, June 2002, OSLO, Norway

  ASCO-PAN ASIA Cancer Conference (2002), New Delhi

  SIOP-ASIA Conference, November, 2002, New Delhi

  Attended NSCLC Workshop (IRESSA), September 2003, CAMBRIDGE, UK

  ASIA PACIFIC CANCER CONFERENCE, October 2003, Indonesia

  American Society of Hematology, December 2003, Sandiego, USA

  European Society of Medical Oncology Conference, October 2004, (Viena) Austria

  Asia Pacific Cancer Conference, September 2005, (Seoul) Korea

  ASCO 2004 & 2006,  USA

  10th International Conference on Malignant Lymphoma Lugano, Switzerland, June, 2008

  Completed Education activity : Update in Oncology conducted by  The American Academy of Continuing Medical Education, November 2007

  International Conf. of Clinical Oncology Society of Australia ( Sidney November 2008 ).

  Attended 20th Asia Pacific Cancer Conference, Tsukuba Japan (Nov. 2009)

  Workshop on how to conduct International Quality Clinical Trial, 2001

  Presented proposal of clinical trial at Indian Co-operative Oncology Network     (ICON) at Tata Memorial Cancer Hospital, Mumbai, February 2003

  Conducted more than 15 international Phase I to Phase III clinical trial as Principal investigator.

  Ongoing Studies –

  Protocol entitled "EPO-ANE-3010/Amendment INT-6 :A Randomized Open-Label, Multicentre, Phase 3 study of Epoetin Alfa plus Standard Supportive Care versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving First-Line Standard Chemotherapy". Protocol No. EPO-ANE-3010
Breast Cancer

  A Multinational, Randomized, Double Blind Study, Comparing the Efficacy of Aflibercept Once Every 2 weeks versus Placebo in Patients Treated with Gemcitabine for Metastatic Pancreatic Cancer. Protocol No. EFC - 10547
Pancreatic Cancer

  Axitinib (AG-013736) As Second Line Therapy For Metastatic Renal Cell Cancer: Axis Trial Protocol No. : A4061032
Renal Cell Carcinoma

  Safety and Efficacy of Recombinant Human Granulocyte-colony Stimulating Factor- rhGCSF (ReliGrast TM or Neupogen®) in Patients with Chemotherapy Induced Neutropenia (Protocol No. : GMX-GCSF-CT001
Chemo induced Neutropenia in Breast Cancer

  A Phase III, Randomized, Double -Blind Study of Galiximab in combination with Rituximab Compared with Rituximab in Combination with placebo for the Treatment of Subjects with Relapsed or Refractory, Follicular Non- Hodgkin's Lymphoma. Study Number: 114-NH-301.
Non- Hodgkin's Lymphoma

  Protocol 276-00/31/08: An Open Label, Multicenter Phase/II Study Of Selective Cyclin Dependent Kinase Inhibitor P276-00 In Combination With Radiation In Subjects With Recurrent And/Or Locally Advanced Squamous Cell Carcinoma Of Head And Neck.
Head And Neck Cancer

  Multicentre, randomised, double-blind, Phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard docetaxel therapy compared to placebo plus standard docetaxel therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy.
NSCLC Lung

  Protocol P1446-05/19/08: An Open Lable, Multicenter Phase 1 Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignacies (Hence Reffered To As 'SERENiTY' Study).
Refractory Cancers

  Follow up & Completed Studies –

  A Multicentre Randomized, Double Blind, Placebo-Controlled, Parallel Arm Study of the Effect of Intravenous AVE0005 (VEGF Trap) Administered Every 2 Weeks in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites. Protocol No. - EFC6125 (AVE0005A/3001)
Ovarian Cancer

  A Pivotal Phase 3 Observer-Blind Randomized Clinical Trial of the Efficacy and Safety of APF 530 Compared to Aloxi for the Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea and Vomiting Following Administration of Moderately or Highly Emetogenic Chemotherapy Regimens". Protocol No:C2006-01
Chemotherapy-Induced Nausea and Vomitings

  A Phase 3b, Randomized, Open-Label Study of Bevacizumab (Avastin®) + Temsirolimus (Torisel®) vs. Bevacizumab (Avastin®) + Interferon-Alfa (Roferon®) as First-Line Treatment in Subjects with Advanced Renal Cell Carcinoma (Wyeth Study)
Renal Cell Carcinoma

  A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib In Metastatic Colorectal Cancer Patients Receiving Irinotecan, 5-Fluorouracil And Leucovorin (Folfiri) As Firstline Treatment. Protocol No. - A6181122
Colorectal Cancer

  Phase III Randomized, Multi Center Study of Sunitinib Malate (SU 011248) or Capecitabine in Subjects with Advanced Breast Cancer who failed both a taxane and an anthracycline chemotherapy regimen or failed with a taxane and for whom further anthracycline therapy is not indicated. Study A6181107
Breast Cancer

  An Open-Label Sunitinib Malate (Su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment. Study A6181114
Breast Cancer

  A Two-Way Crossover Experimental Evaluation Of Relative Bioavailability Of Two Formulations Of Temozolomide 250 Mg Capsules In Adult Human Male And/Or Female Patients Under Fasting Conditions. Protocol No. - 141-06
CNS Malignancy (Glioblastoma Multiforme)

  International, Randomized,Open-label,phase 3 Trial of Paclitaxel / Carboplatin Plus Pf-3512676 Versus Paclitaxel / Carboplatin Alone As First-Line Treatment Of Patients With Advanced Non-Small Cell Lung Cancer. Protocol No. - A8501001
Non-Small Cell Lung Cancer

  A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment for Advanced Non-Small Cell Lung Cancer. Protocol No. - H3E-MC-JMEN
Non-Small Cell Lung Cancer

 “A pilot study of BEACOPP (Basic & “modified escalated”) chemotherapy with our without involved field radiotherapy in Hodgkin’s disease: A cost effective & risk stratified protocol in Indian context” (Published in Indian Journal of Medical & Paediatric Oncology - ISSN 0971-5851)

  Activity of specific inhibitor of epidermal growth factor receptor (Gefitinib) in refractory Non-Small-Cell Cancer (NSCLC) - Published in Current Medical Trends - ISSN 0972-3390.

  Review article: systemic treatment of primary breast cancer JAPI, Vol. No. 49, April, 2001 (ISSN-0004-5772)

  “Modified BEACOPP regime as a cost-effective therapy for unfavourable Hodgkin’s disease in underprivileged countries” (Shantanu Sharma, Naresh Somani, S.C. Pande, Nidhi Patni). Presented at 38th Annual Conference of the International Society of Paediatric Oncology (SIOP), Geneva, Switzerland, Sept. 2006 and published in “Pediatric Blood & Cancer” Volume 47, Issue 4, Oct. 1, 2006 PJ.017, ISSN 1545-5009

  Review article: overview of management of primary pulmonary lymphoma, Current Medical Trends (ISSN 0972-3390)

  Review article, drug review: Topotecan, Journal of Indian Society of Med. & Ped. Oncology, 2001 -  ISSN 0971-5851

 Effect of climatic variation on flow rates in normal subject and Asthamatics. Somani N., Kotia Amit, Mathur U.S.

  A comparative study of tobacco consumption (smoking & chewing on certain cardiovascular & metabolic parameters – Somani Naresh, Kotia Amit, Mathur U.S. Rajasthan Medical Journal, India

  Profile of vertebral secondaries in non-mammary carcinoma; Journal of association of physicians of India – Vol. No. 49, Jan. 2001 (ISSN 0004-5772)

  Clinical profile of Lung Cancer in Indian Context Thesis (Dissertation), submitted to University of Rajasthan for award degree of M.D., 1996    

  "Induction chemotherapy followed by concurrent chemo radiotherapy in locally advanced inoperable Head & Neck cancer": feasibility and response in India context". Presented in 20th Asia Pacific Cancer Conference, Tsukuba Japan (Nov. 2009)

  BEACOPP Chemotherapy in Hodgkin’s Lymphoma: A cost effective protocol in Indian context presented in ESMO, Vienna (Austral) 2004

  Presented paper on Role of Cisplatin & Irinotecan (CPT-11) in Small-Cell-Lung Cancer in ASIA PACIFIC CANCER CONFERENCE, October 2003, Indonesia

  “Complementary and Alternate Medicine in Indian Context” presented in Asia Pacific Cancer Conference, Seoul, Korea 2005

 Role of BEACOPP Chemotherapy in Hodgkin’s Lymphoma presented in APICON, January 2004, Hyderabad, India

  Paper on Hodgkin’s Lymphoma was included in young scientist award competition of  ISMPO conference, Banglore 2004

  Role of Amifostine in preventing side effects concurrent chemotherapy in head & neck cancer patients Patni N., Bapna A., Somani N., Gupta A., Venkat Ratnam N. presented  in 40th ASCO 2004

 Prospective study using PCD-E combination therapy M.D.S. Protocol. Kumar Ravi, Parikh P.M., Malhotra H., Somani N., C. Gangadharan V. (Presented in 11th annual conference of Indian Society of Med. & Ped. Oncology of India), January 2001

  Concurrent chemo-radiotherapy for advanced Head & Neck Cancer. Protocol ICON / H&N / 9905a (Bhalawat R., Somani N., Pai V.R. presented in 11th annual conference of Indian Society of Med. & Ped. Oncology of India, January 2001

  Organizing Secretary of “Release of ICCN (Indian Co-operative Guidelines) – An initiative in collaboration with NCCN, USA to formulate Indian guidelines
October 2005, Jaipur. (Inaugurated by the then Vice President of India
Mr. B.S. Sekhawat.

  International Seminar on “State of the Art in Oncology”, BMCHRC, October 2005 Jaipur.

  Organizing Secretary of International conference on Advances in Management of Breast & Gynaecological Cancers “BMCON II” March 4th -5th 2006

  Organizing Secretary of “16th ICON Conference ” March 2007, Jaipur

  Organised more than 10 CME in field of Oncology for clinicians in Jaipur & remote places all over Rajasthan.

  Founder & Director of  Clinical Research Organization - SoMex Research & Health Pvt. Ltd. for clinical trials.

  Founder & Co-Director of Somani Hospital, Jaipur (A multi facilities Health Center)
WebSite: www.somexresearch.com,

Email: drsomani@somexresearch.com
Somani Hospital : A multi specialty health center in heart of city of Jaipur.

  Published a book “Cancer Upchaar” in Hindi for General Public & Patients to understand various aspects of cancer. (Released by Dr. V. Shanta – Executive Director of Cancer Institute (WIA), Chennai & Roman Megasasy award winner)

  Published numerous articles in various National Newspapers & National Magazines.

  Delivered talk many times on Cancer Awareness and Tobacco Cassation on T.V. Channels & Radio

  Treating approximately 20% cancer patients free of cost at BMCHRC.

  Established & ran Rural Cancer Clinic at Shekhawati Zanana Hospital, Sikar (Rajasthan), 1999-2006.

  Incharge & established rural cancer clinic at Village Bagar, Distt. Jhunjhunu, Rajasthan, 1999 - till date.

  Doing free Hepatitis - B vaccination since last 8 year in Village Bagar to all pediatric population.

  Organized and participated in more than 150 cancer detection and check-up camps in rural parts of state of Rajasthan

  Cancer Help Line (Ph. No. 0141-3212996) – A free telephonic and online consultation for public and health professional about cancer prevention, awareness and treatment.

  Oncofact : a free message service to all medical doctors of Rajasthan to update them about advances in oncology.

  Extension lectures on Oncology to post graduate students of Shalya in National Institute of Ayurveda, Jaipur in year 2004

  DNB Students of surgical oncology, radiation oncology & undergraduate staff, nursing staff of BMCHRC, Jaipur.